Finding the right treatment for someone with Crohn’s disease or ulcerative colitis is more of an art than a science. The ...

Mount Sinai and King Saud University Medical City in Riyadh, Saudi Arabia, today announced a three-year collaboration aimed ...

"This disease involves episodes known as flares, which are often unpredictable, so the treatment is constantly being adjusted. So far, it has not been possible to predict the individual course of the ...

Microbiota therapeutics, such as fecal microbiota transplantation (FMT), could offer more diverse, personalized treatment options for patients with inflammatory bowel disease (IBD), particularly for ...

Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The treatment landscape for inflammatory ...

Teva Pharmaceutical Industries (NYSE:TEVA) and Sanofi reported positive 44 week data from the RELIEVE UCCD study for ...

New York, NY, and Riyadh, Saudi Arabia [March 3, 2026] — Mount Sinai and King Saud University Medical City in Riyadh, Saudi Arabia, today announced a three-year collaboration aimed at better ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Three new IL-23 inhibitors have been approved for IBD, ...

(BPT) – Living with inflammatory bowel disease (IBD), such as Crohn’s disease and ulcerative colitis (UC), can be extremely frustrating to people living with the conditions and significantly affect ...